Donepezil is a representative symptomatic therapy for mild and moderate AD as an AChE inhibitor (Bohnen et al., 2005), and recent researches have revealed that it also can suppress inflammation and oxidative stress (Saxena et al., 2008; Yoshiyama et al., 2010). This evidence concerns the gene ACHE and Alzheimer disease.